3-Ethynylaniline CAS 54060-30-9 Mimọ>99.0% (GC) Erlotinib Hydrochloride Intermediate

Apejuwe kukuru:

Orukọ Kemikali: 3-Ethynylaniline

Synonyms: 3-Aminophenylacetylene

CAS: 54060-30-9

Mimọ:> 99.0% (GC)

Irisi: Imọlẹ Yellow si Brown Liquid

Agbedemeji ti Erlotinib Hydrochloride (CAS: 183319-69-9)

Olubasọrọ: Dokita Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Olupese asiwaju ati olupese ti Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis (2-Methoxyethoxy) -3H-Quinazolin-4-ọkan CAS 179688-29-0
Please contact: alvin@ruifuchem.com

Kemikali Properties:

Orukọ Kemikali 3-Ethynylaniline
Awọn itumọ ọrọ sisọ 3-Aminophenylacetylene
Nọmba CAS 54060-30-9
NỌMBA CAT RF-PI2241
Iṣura Ipo Ninu Iṣura, Agbara iṣelọpọ 50MT / osù
Ilana molikula C8H7N
Òṣuwọn Molikula 117.15
Ni imọlara Air Sensitive, Light kókó
Ojuami farabale 120℃/20 mmHg
Omi Solubility Ailopin ninu Omi
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Ina Yellow to Brown Liquid
Mimọ / Analysis Ọna > 99.0% (GC)
Omi nipa Karl Fischer <0.50%
Aloku lori Iginisonu <0.20%
Lapapọ Awọn Aimọ <1.00%
Walẹ Kan pato (20/20℃) 1.041 ~ 1.048
Atọka Refractive n20/D 1.614 ~ 1.6195
Infurarẹẹdi julọ.Oniranran Ni ibamu si Eto
Proton NMR julọ.Oniranran Ni ibamu si Eto
Igbeyewo Standard Standard Enterprise
Lilo Elegbogi Intermediate;Erlotinib Hydrochloride Intermediate

Package & Ibi ipamọ:

Package: Igo Fluorinated, 25kg/Drum, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

1

FAQ:

Ohun elo:

3-Ethynylaniline, ti a tun mọ ni 3-Aminophenylacetylene (CAS: 54060-30-9) ni a lo bi agbedemeji elegbogi.3-Ethynylaniline jẹ agbedemeji ti Erlotinib Hydrochloride (CAS: 183319-69-9).Erlotinib Hydrochloride jẹ inhibitor tyrosine kinase moleku kekere eyiti o ṣe atunṣe lori awọn olugba idagba epidermal, hydrochloride kan ti erlotinib, oogun ti a fojusi molikula.Awọn ipinfunni Ounjẹ ati Oògùn AMẸRIKA (FDA) ti fọwọsi erlotinib (Tarceva) ni idapo pẹlu gemcitabine bi itọju laini akọkọ fun ilọsiwaju agbegbe ati akàn pancreatic metastatic.O jẹ lilo akọkọ bi itọju keji tabi laini kẹta fun ilọsiwaju agbegbe tabi akàn ẹdọfóró ti kii-kekere sẹẹli (NSCLC) ati bi itọju fun akàn pancreatic.O ti wa ni lo bi a tyrosine inhibitor fun NSCLC itọju.Erlotinib Hydrochloride, quinazoline ti ari kekere moleku inhibitor ti epidermal idagba receptor (EDGFR) tyrosine kinase, ti a fọwọsi ni Kọkànlá Oṣù, 2004, fun awọn itọju ti to ti ni ilọsiwaju tabi metastatic akàn ẹdọfóró ti kii-kekerecell.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa